Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Current Size And Growth Outlook For The GLP-1 Receptor Agonist Market?

The market size for GLP-1 receptor agonist has seen consistent growth in the past few years. Its size is expected to increase from $13.58 billion in 2024 to $14.09 billion in 2025, with a compound annual growth rate (CAGR) of 3.8%. The expansion during the historical period was driven by factors such as an increase in diabetes instances, clinical effectiveness, improved patient awareness and approval, global health campaigns, and patient preference for injectable treatments.

The market for GLP-1 receptor agonist is forecasted to witness substantial growth in the upcoming years. The market is set to surge to “$17.36 billion in 2029” with a compound annual growth rate (CAGR) of 5.4%. The expected growth in this period is due to the increasing focus on lifestyle management, adoption of personalized medicine, broadening indications, the creation of next-gen products, and integration into combination therapies. Key trends within this forecasting period include the launch of oral formulations, emphasis on combination therapies, strategic alliances, reimbursement procedures and accessibility, and patient-oriented strategies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9631&type=smp

What External And Internal Drivers Are Influencing The GLP-1 Receptor Agonist Market?

The escalating rates of diabetes are anticipated to boost the GLP-1 receptor agonist market in the future. Diabetes is a long-term ailment that occurs when the pancreas either fails to generate adequate insulin or the body cannot efficiently use the insulin it has. Elevated blood sugar levels often indicate the metabolic condition known as diabetes mellitus. GLP-1 receptor agonist is employed in diabetes management to prompt the body to generate more insulin, thus reducing blood sugar levels. Consequently, the escalating rates of diabetes will accelerate market growth. For example, in March 2024, the Office for Health Improvement and Disparities, a government department in the UK, reported that the proportion of individuals with type-1 diabetes who received all eight suggested care processes had increased by 22% between March 2022 and March 2023. Simultaneously, the number increased by 21% for type-2 diabetes, while the percentage reaching the target HbA1c levels increased to an unprecedented 37.9%, according to the National Diabetes Audit (NDA). Thus, the escalating rates of diabetes are acting as a catalyst for the growth of the GLP-1 receptor agonist market.

What Is The Segment Breakdown Of The GLP-1 Receptor Agonist Market?

The glp-1 receptor agonist market covered in this report is segmented –

1) By Drug Class: Exenatide, Liraglutide, Dulaglutide, Lixisenatide, Other Drugs

2) By Route Of Administration: Parenteral, Oral

3) By End Users: Hospitals, Surgical Clinics, Other Users

Subsegments:

1) By Exenatide: Byetta, Bydureon

2) By Liraglutide: Victoza, Saxenda

3) By Dulaglutide: Trulicity

4) By Lixisenatide: Adlyxin

5) By Other Drugs: Semaglutide, Tirzepatide, Others

How Are Global Trends Impacting The Development Of The GLP-1 Receptor Agonist Market?

In the GLP-1 receptor agonist market, a key trend that is gaining traction is product innovation. The main companies in this market are concentrating on creating novel solutions to solidify their standing. For example, a pharmaceutical company based in the US, Eli Lilly and Company, known for their life-improving medications, rolled out a new FDA-sanctioned product named Mounjaro in May 2022. Mounjaro is a GIP and GLP-1 receptor agonist, specifically engineered using a unique molecule that activates the body’s receptors for the incretin hormones GIP and GLP-1. Available as a pen auto-injector, it features a pre-attached, concealed needle, eliminating the need for patients to handle or observe it. It is offered in six different doses.

Who Are The Major Stakeholders Operating In The GLP-1 Receptor Agonist Market?

Major companies operating in the GLP-1 receptor agonist market include Novo Nordisk A/S, Sanofi SA, Eli Lilly and Company, AstraZeneca Inc., Boehringer Ingelheim International GmbH, Hanmi Pharm Co. Ltd., Pfizer Inc., Amgen Inc., Innovent Biologics Inc., Jiangsu Hengrui Medicine Co., Sun Pharmaceuticals Industries Ltd., PegBio Co. Ltd., Zealand Pharma A/S, Bristol-Myers Squibb Company, Chongqing Lummy Pharmaceutical Co. Ltd., Daiichi Sankyo Company Limited, Dong-A ST Co. Ltd., Eisai Co. Ltd., HanAll Biopharma Co. Ltd., Ipsen SA, Johnson & Johnson, Merck & Co. Inc., Novartis AG

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/glp-1-receptor-agonist-global-market-report

Which Region Is Likely To Register The Fastest Growth In The GLP-1 Receptor Agonist Market?

North America was the largest region in the GLP-1 receptor agonist market in 2024. Asia-Pacific is expected to be the fastest-growing region in the GLP-1 receptor agonist market report during the forecast period. The regions covered in the GLP-1 receptor agonist market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=9631&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model